IAVI Financial Snapshot

 

2012 R&D Program Expenses
(US $)

2012 Expenses
(US $)

Applied research 24,525,940  
Preclinical development 8,833,142  
Clinical trials 14,942,097  
Cohort and site development 4,153,763  
Research and development 52,454,942 52,454,942
Fundraising   2,878,050
Vaccine advocacy, education and
policy/access
  6,766,992
General and administrative   9,825,676
Other Expenses   19,470,718

Total Expenses (US $)

 

71,925,660

© International AIDS Vaccine Initiative, 125 Broad Street, 9th Floor New York, NY 10004 USA
T +1.212.847.1055 :: F +1.212.847.1112 :: www.iavi.org